Neumora Therapeutics Inc (NMRA)

10:32 AM

Needham & Company LLC Reiterates "Buy" Rating for Neumora Therapeutics (NASDAQ:NMRA) - MarketBeat

10:32 AM

May 14, 2025

Neumora Therapeutics (NASDAQ:NMRA) Posts Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

May 14, 2025

May 14, 2025

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm - PR Newswire

May 14, 2025

May 13, 2025

Neumora Therapeutics, Inc.: Strengthened Financial Position and Strategic Operational Enhancements Drive Buy Rating - TipRanks

May 13, 2025

May 13, 2025

Neumora Therapeutics Venture Debt Facility - Leerink Partners

May 13, 2025

May 13, 2025

Neumora Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 13, 2025

May 12, 2025

Earnings call transcript: Neumora Therapeutics Q1 2025 Sees Net Loss, Stock Rises - Investing.com

May 12, 2025

May 12, 2025

Neumora Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025

May 12, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Rating of "Hold" from Brokerages - MarketBeat

May 12, 2025

May 11, 2025

Will Neumora Therapeutics (NASDAQ:NMRA) Spend Its Cash Wisely? - Yahoo Finance

May 11, 2025

May 10, 2025

Neumora Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025NMRA - ACCESS Newswire

May 10, 2025

May 10, 2025

Neumora Therapeutics (NMRA) Expected to Announce Earnings on Monday - Defense World

May 10, 2025

May 09, 2025

Neumora Therapeutics Inc (NASDAQ: NMRA): What Matters Now - Stocksregister

May 09, 2025

May 08, 2025

Schonfeld Strategic Advisors LLC Buys 381,676 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat

May 08, 2025

May 07, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of “Hold” by Analysts - Defense World

May 07, 2025

May 06, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

May 06, 2025

May 05, 2025

Neumora Therapeutics (NMRA) Projected to Post Quarterly Earnings on Monday - MarketBeat

May 05, 2025

May 04, 2025

Invesco Ltd. Raises Holdings in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

May 04, 2025

May 02, 2025

NMRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - NatLawReview.com

May 02, 2025

May 02, 2025

Nothing is Better Than Neumora Therapeutics Inc (NMRA) stock at the moment - Sete News

May 02, 2025

May 02, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stock Position Increased by Wells Fargo & Company MN - Defense World

May 02, 2025

May 01, 2025

Should investors be concerned about Neumora Therapeutics Inc (NMRA)? - uspostnews.com

May 01, 2025

Apr 30, 2025

NMRA stock rated an Underperform by BofA Securities - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Wainwright maintains $18 target on Neumora Therapeutics stock By Investing.com - Investing.com Canada

Apr 30, 2025

Apr 30, 2025

Neumora Therapeutics (NASDAQ:NMRA) versus Big Cypress Acquisition (OTCMKTS:BCYP) Head to Head Comparison - Defense World

Apr 30, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Legal & General Group Plc Buys 50,289 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - The AM Reporter

Apr 29, 2025

Apr 28, 2025

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 - Yahoo Finance

Apr 28, 2025

Apr 26, 2025

Investors Who Lost Money on Neumora Therapeutics, Inc. (NMRA) Should Contact Levi & Korsinsky About Pending Class ActionNMRA - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Shares Bought by Capital International Investors - MarketBeat

Apr 26, 2025

Apr 25, 2025

It is Poised to be a Bull Market for Neumora Therapeutics Inc (NMRA) - Sete News

Apr 25, 2025

Apr 24, 2025

NMRA Stock Sees Surge of Approximately 8.37% in Last Five Days - knoxdaily.com

Apr 24, 2025

Apr 23, 2025

NMRA’s valuation metrics: A comprehensive analysis - uspostnews.com

Apr 23, 2025

Apr 22, 2025

Former Neumora CEO to lead Galapagos spinout - BioPharma Dive

Apr 22, 2025

Apr 19, 2025

Franklin Resources Inc. Sells 44,345 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Apr 19, 2025

Apr 17, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $9.29 Consensus PT from Analysts - MarketBeat

Apr 17, 2025

Apr 17, 2025

Alliancebernstein L.P. Sells 22,930 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Apr 17, 2025

Apr 15, 2025

Neumora Therapeutics (NASDAQ:NMRA) Receives Buy Rating from Needham & Company LLC - MarketBeat

Apr 15, 2025

Apr 13, 2025

Vanguard Group Inc. Purchases 195,142 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Apr 13, 2025

Apr 12, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Rating of “Hold” by Analysts - Defense World

Apr 12, 2025

Apr 12, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Neumora Therapeutics (NASDAQ:NMRA) - Defense World

Apr 12, 2025

Apr 10, 2025

KLP Kapitalforvaltning AS Makes New Investment in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World

Apr 10, 2025

Apr 09, 2025

Neumora Therapeutics, Inc.: Strategic Advancements and Optimism Drive Buy Rating - TipRanks

Apr 09, 2025